Collectively, our study demonstrates that CPVL directly interacts with BTK to downregulate the STAT1 phosphorylation through promoting p300-mediated STAT1 acetylation, supporting the pursuit of CPVL as a potential target for glioma intervention. Here, STAT1 is linked to central nervous system cancer.